Your browser doesn't support javascript.
loading
Point Prevalence Survey of Antimicrobial Use in Four Tertiary Care Hospitals in Mexico.
Zumaya-Estrada, Federico A; Ponce-de-León-Garduño, Alfredo; Ortiz-Brizuela, Edgar; Tinoco-Favila, Juan Carlos; Cornejo-Juárez, Patricia; Vilar-Compte, Diana; Sassoé-González, Alejandro; Saturno-Hernandez, Pedro Jesus; Alpuche-Aranda, Celia M.
Afiliação
  • Zumaya-Estrada FA; Center for Infectious Diseases Research (CISEI), National Institute of Public Health (INSP), Cuernavaca, C.P. 62100, Morelos, México.
  • Ponce-de-León-Garduño A; Infectology Department, National Institute of Medical Sciences and Nutrition "Salvador Zubirán", Ciudad de México, C.P. 14080, México.
  • Ortiz-Brizuela E; Infectology Department, National Institute of Medical Sciences and Nutrition "Salvador Zubirán", Ciudad de México, C.P. 14080, México.
  • Tinoco-Favila JC; Infectology Department, Hospital General 450, Secretary of Health of Durango, Durango, C.P. 34206, Durango, México.
  • Cornejo-Juárez P; Infectious Diseases Department, National Institute of Cancer (INCan), Ciudad de México, C.P. 14080, México.
  • Vilar-Compte D; Infectious Diseases Department, National Institute of Cancer (INCan), Ciudad de México, C.P. 14080, México.
  • Sassoé-González A; Epidemiological Intelligence Unit, High Specialty Regional Hospital of Ixtapaluca, Estado de México, C.P. 56530, México.
  • Saturno-Hernandez PJ; Center for Evaluation and Surveys Research (CIEE), National Institute of Public Health (INSP), Cuernavaca, C.P. 62100, Morelos, México.
  • Alpuche-Aranda CM; Center for Infectious Diseases Research (CISEI), National Institute of Public Health (INSP), Cuernavaca, C.P. 62100, Morelos, México.
Infect Drug Resist ; 14: 4553-4566, 2021.
Article em En | MEDLINE | ID: mdl-34754203
PURPOSE: To describe the antimicrobial use in four tertiary care hospitals in Mexico. PATIENTS AND METHODS: Point prevalence surveys (PPSs) were conducted on medical records of hospitalized patients with prescribed antimicrobials (AMs) in four tertiary care hospitals in Mexico in 2019. Prevalence estimates and descriptive statistics were used to present the collected data on antimicrobial prescribing and microbiological studies. RESULTS: The prevalence of patients with prescribed AMs among the hospitals ranged from 47.1% to 91.3%. Antibiotics for systemic use (J01s) were the most prescribed (84.6%, [95% CI: 81.5-87.3]), mainly extended-spectrum J01s: third-generation cephalosporins 19.8% [95% CI: 16.8-23.1], and carbapenems 17.0% [95% CI: 14.2-20.2]. Antibiotic treatments were largely empirical, with no planned duration or review dates. The ceftriaxone use was excessive and prolonged. No formal reference guidelines for antimicrobial prescribing were available in the hospitals. Multidrug-resistant Escherichia coli and ESKAPE pathogens were identified in all hospitals. CONCLUSION: This study describes the extensive use of antimicrobials and broad-spectrum antibiotics for systemic use in Mexican hospitals, along with the presence of resistant pathogens to the antibiotics frequently used in the hospitals surveyed.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prevalence_studies / Qualitative_research / Risk_factors_studies País/Região como assunto: Mexico Idioma: En Revista: Infect Drug Resist Ano de publicação: 2021 Tipo de documento: Article País de publicação: Nova Zelândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prevalence_studies / Qualitative_research / Risk_factors_studies País/Região como assunto: Mexico Idioma: En Revista: Infect Drug Resist Ano de publicação: 2021 Tipo de documento: Article País de publicação: Nova Zelândia